[1]
“Formulation Development, Characterization, and Evaluation of Controlled Nasal Drug Delivery Systems for Cefuroxime Axetil”, AJP, vol. 14, no. 4, Nov. 2020, doi: 10.22377/ajp.v14i4.3830.